Kilter Group’s Medpace MEDP Stock Holding History

Kilter Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4K	Buy	+28	New	+$14.3K	0.01%	313
2025 Q3	–	Sell	-8	Closed	-$2.51K	–	1288
2025 Q2	$2.51K	Buy	+8	New	+$2.4K	﹤0.01%	556

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Kilter Group's MEDP Position: Q1 2026 in Review

Kilter Group opened a new position in Medpace (MEDP) in Q1 2026: 28 shares worth $13.4K. The stake represents 0.01% of the portfolio and ranks #313 among its holdings. This is a return to the name: Kilter Group previously reported a position in MEDP as recently as Q2 2025.

Kilter Group first reported a position in MEDP in Q2 2025 and has held it in 2 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Kilter Group held 28 shares of Medpace worth $13.4K as of Q1 2026.
Medpace was a new Kilter Group position in Q1 2026.
Medpace made up 0.01% of Kilter Group's portfolio in Q1 2026, its #313 holding.
Kilter Group first reported a position in Medpace in Q2 2025 and has held it in 2 quarters since.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.